Understanding Cancer in Minority Patients with Gastric and Lung Cancer
Admin Core
This effort aims to create a special collection of cancer models from minority patients with gastric and lung cancer to help guide personalized treatment decisions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11168886 on NIH RePORTER |
What this research studies
We are building a unique collection of cancer models, called patient-derived xenografts (PDXs), using tumor samples from minority patients with gastric and lung cancer. These models are created by growing a patient's tumor cells in a lab setting, allowing researchers to study how different cancers behave and respond to treatments. Our goal is to use these specific models to better understand cancer in diverse populations and find more effective, personalized treatment options. This work is coordinated across several major cancer centers to ensure a broad and representative collection.
Who could benefit from this research
Good fit: Ideal candidates for contributing to this type of research would be minority patients diagnosed with gastric or lung cancer who are willing to donate tumor samples.
Not a fit: Patients without gastric or lung cancer, or those not belonging to racial/ethnic minority populations, may not directly benefit from this specific collection of models.
Why it matters
Potential benefit: If successful, this work could lead to more precise and effective cancer treatments tailored specifically for minority patients with gastric and lung cancer.
How similar studies have performed: While the creation of PDX models is an established technique, this large-scale collection specifically focused on minority populations with gastric and lung cancer represents a significant and novel effort.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Carvajal Carmona, Luis Guillermo — University of California at Davis
- Study coordinator: Carvajal Carmona, Luis Guillermo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.